Analysis of SOX10 mutations identified in Waardenburg-Hirschsprung patients: Differential effects on target gene regulation

Journal of Cellular Biochemistry

Volumn 90, Issue 3, 2003, Pages 573-585

  Chan, Kwok Keung ^a   Wong, Corinne Kung Yen ^a   Lui, Vincent Chi Hang ^b   Tam, Paul Kwong Hang ^b   Sham, Mai Har ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

HMG domain; Intestinal aganglionosis; Neural crest; P0; RET; SOX10; Waardenburg Hirschsprung syndrome

Indexed keywords

HIGH MOBILITY GROUP B PROTEIN; LUCIFERASE; MUTANT PROTEIN; MYELIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

AGANGLIONOSIS; ANIMAL CELL; ARTICLE; BINDING SITE; CENTRAL NERVOUS SYSTEM; GENE; GENE ACTIVATION; GENE CONTROL; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEARING DISORDER; HIRSCHSPRUNG DISEASE; HUMAN; MYELINATION; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PIGMENTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; REPORTER GENE; SEQUENCE HOMOLOGY; SOX10 GENE; SYMPTOMATOLOGY; WAARDENBURG SYNDROME;

MAMMALIA;

EID: 0141988843     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10656     Document Type: Article

References (43)

1. Ambani LM. 1983. Waardenburg and Hirschsprung syndromes. J Pediatr 102:802.
2. Amiel J, Lyonnet S. 2001 Hirschsprung disease, associated syndromes, and genetics: A review. J Med Genet 38:729-739.
3. Badner JA, Chakravarti A. 1990. Waardenburg syndrome and Hirschsprung disease: Evidence for pleiotropic effects of a single dominant gene. Am J Med Genet 35:100-104.
4. Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens M. 2001. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet 10:2783-2795.
5. Bondurand N, Kuhlbrodt K, Pingault V, Enderich J, Sajus M, Tommerup N, Warburg M, Hennekam RC, Read AP, Wegner M, Goossens M. 1999. A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum Mol Genet 8:1785-1789.
6. Bondurand N, Pingault V, Goerich DE, Lemort N, Sock E, Caignec CL, Wegner M, Goossens M. 2000. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 9:1907-1917.
7. Bowles J, Schepers G, Koopman P. 2000. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227:239-255.
8. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier C, Wegner M. 2001. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15:66-78.
9. Chan KK, Tsui SK, Ngai SM, Lee SM, Kotaka M, Waye MM, Lee CY, Fung KP. 2000. Protein-protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47. J Cell Biochem 76:499-508.
10. Herbarth B, Pingault V, Bondurand N, Kuhlbrodt K, Hermans-Borgmeyer I, Puliti A, Lemort N, Goossens M, Wegner M. 1998. Mutation of the Sry-related Sox10 gene in dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci USA 95:5161-5165.
11. Inoue K, Tanabe Y, Lupski JR. 1999. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann Neurol 46:313-318.
12. Kamachi Y, Uchikawa M, Kondoh H. 2000. Pairing SOX off: With partners in the regulation of embryonic development. Trends Genet 16:182-187.
13. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. 1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18:237-250.
14. Lang D, Chen F, Milewski R, Li J, Lu MM, Epstein JA. 2000. Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J Clin Invest 106:963-971
15. Lang D, Epstein JA. 2003. Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet 12:937-945.
16. Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR. 2000. Direct regulation of the microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J Biol Chem 275:37978-37983.
17. Lupski JR. 1992. An inherited DNA rearrangement and gene dosage effect are responsible for the most common autosomal dominant peripheral neuropathy: Charcot-Marie-Tooth disease type 1A. Clin Res 40:645-652.
18. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360.
19. Ng EK, Chan KK, Wong CH, Tsui SK, Ngai SM, Lee SM, Kotaka M, Lee CY, Waye MM, Fung KP. 2002. Interaction of the heart-specific LIM domain protein, FHL2, with DNA-binding nuclear protein, hNP220. J Cell Biochem 84:556-566.
20. Paratore C, Eichenberger C, Suter U, Sommer L. 2002. Sox10 haploinsufficiency affects maintenance of progenitor cells in a mouse model of Hirschsprung disease. Hum Mol Genet 11:3075-3085.
21. Paratore C, Goerich DE, Suter U, Wegner M, Sommer L. 2001. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development 128:3949-3961.
22. Peirano RI, Goerich DE, Riethmacher D, Wegner M. 2000. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol 20:3198-3209.
23. Peirano RI, Wegner M. 2000. The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res 28:3047-3055.
24. Pevny LH, Lovell-Badge R. 1997. Sox genes find their feet. Curr Opin Genet Dev 7:338-344.
25. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccherini I, Romeo G, Smith JC, Read AP, Wegner M, Goossens M. 1998. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18:171-173.
26. Pingault V, Bondurand N, Le Caignec C, Tardieu S, Lemort N, Dubourg O, Le Guern E, Goossens M, Boespflug-Tanguy O. 2001. The SOX10 transcription factor: Evaluation as a candidate gene for central and peripheral hereditary myelin disorders, J Neurol 248:496-499.
27. Pingault V, Girard M, Bondurand N, Dorkins H, Van Maldergem L, Mowat D, Shimotake T, Verma I, Baumann C, Goossens M. 2002. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Hum Genet 111:198-206.
28. Pingault V, Guiochon-Mantel A, Bondurand N, Faure C, Lacroix C, Lyonnet S, Goossens M, Landrieu P. 2000. Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: A developmental "neural crest syndrome" related to a SOX10 mutation. Ann Neurol 48:671-676.
29. Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ. 2000. Transcription factor hierarchy in Waardenburg syndrome: Regulation of MITF expression by SOX10 and PAX3. Hum Genet 107:1-6.
30. Potterf SB, Mollaaghababa R, Hou L, Southard-Smith EM, Hornyak TJ, Arnheiter H, Pavan WJ. 2001. Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol 237:245-257.
31. Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Saberan-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Levy N, Clarac F, Cau P, Pellissier JF, Fontes M. 2002. Brain 125:2213-2221.
32. Shah KN, Dalal SJ, Desai MP, Sheth PN, Joshi NC, Ambani LM. 1981. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease: Possible variant of Waardenburg syndrome. J Pediatr 99:432-435.
33. Sham MH, Lui VC, Chen BL, Fu M, Tam PK. 2001a. Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome. J Med Genet 38:E30.
34. Sham MH, Lui VC, Fu M, Chen B, Tam PK. 2001b. SOX10 is abnormally expressed in aganglionic bowel of Hirschsprung's disease infants. Gut 49:220-226.
35. Southard-Smith EM, Angrist M, Ellison JS, Agarwala R, Baxevanis AD, Chakravarti A, Pavan WJ. 1999. The Sox10(Dom) mouse: Modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res 9:215-225.
36. Southard-Smith EM, Kos L, Pavan WJ. 1998. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 18:60-64.
37. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16:165-170.
38. Taraviras S, Marcos-Gutierrez CV, Durbec P, Jani H, Grigoriou M, Sukumaran M, Wang LC, Hynes M, Raisman G, Pachnis V. 1999. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126:2785-2797.
39. Taraviras S, Pachnis V. 1999. Development of the mammalian enteric nervous system. Curr Opin Genet Dev 9:321-327.
40. Touraine RL, Attie-Bitach T, Manceau E, Korsch E, Sarda P, Pingault V, Encha-Razavi F, Pelet A, Auge J, Nivelon-Chevallier A, Holschneider AM, Munnes M, Doerfler W, Goossens M, Munnich A, Vekemans M, Lyonnet S. 2000. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet 66:1496-1503.
41. Verastegui C, Bille K, Ortonne JP, Ballotti R. 2000. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem 275:30757-30760.
42. Wegner M. 1999. From head to toes: The multiple facets of Sox proteins. Nucleic Acids Res 27:1409-1420.
43. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A. 2000. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034.